ARTICLE | Finance
Sweet sound
Otonomy's $49M series D provides runway to commercialization of ear drug
May 5, 2014 7:00 AM UTC
Mezzanine investors lined up for Otonomy Inc.'s $49 million series D round as the ear disorder play ramps up to launch its first product in 2016.
Last week's round included new investors Jennison Associates; Perceptive Advisors; Federated Kaufmann Funds; Clough Capital Partners; Ally Bridge Group; and undisclosed institutional investors...